Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001745347-26-000002
Filing Date
2026-01-08
Accepted
2026-01-08 21:03:09
Documents
1
Period of Report
2026-01-07

Document Format Files

Seq Description Document Type Size
1 form4-01092026_020105.html 4  
1 form4-01092026_020105.xml 4 7170
  Complete submission text file 0001745347-26-000002.txt   8609
Mailing Address 655 THIRD AVENUE SUITE 1115 NEW YORK NY 10017
Business Address 655 THIRD AVENUE SUITE 1115 NEW YORK NY 10017 646-860-7985
MeiraGTx Holdings plc (Issuer) CIK: 0001735438 (see all company filings)

EIN.: 981448305 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O MEIRAGTX HOLDINGS PLC 655 THIRD AVENUE -- SUITE 1115 NEW YORK NY 10017
Business Address
Zeldin Robert K (Reporting) CIK: 0001745347 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38520 | Film No.: 26521175